Berger, K. L., Scherer, J., Ranga, M., Sha, N., Stern, J. O., Quinson, A., & Kukolj, G. (2015). Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies. Antimicrob Agents Chemother.

Berger, K. L., J. Scherer, M. Ranga, N. Sha, J. O. Stern, A.-M Quinson, a G. Kukolj. "Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 Following Treatment With Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies." Antimicrob Agents Chemother 2015.

Berger, K. L., et al. "Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 Following Treatment With Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies." Antimicrob Agents Chemother 2015.